Healthcare | March 02, 2026
Zenex Animal Health makes strategic European play with VievePharm acquisition
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
The Profit After Tax (PAT) for Q3 FY26 was Rs 49.68 crore, compared to Rs 46.78 crore in Q3 FY25
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
On segmental performance, API revenues were largely stable at Rs. 454.3 crore for Q3 FY26, down 1% YoY
The Poultry Healthcare Division delivered a strong performance, posting 32% revenue growth in Q3 FY26 and 17% growth over the nine-month period
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
